| Expected to Further Enhance the Competitiveness in CDISC Based Global Clinical Trial Data Management & Analysis
JNPMEDI (CEO, Kwunho Jeong) introduced on the 20th, the Executive Director HyunSoo Lee, who has over 20 years of careers in clinical trial statistical analysis. Through this recruitment, it is expected to strenghthen JNPMEDI’s capabilities in global clinical trial data management and analysis.
Director HyunSoo Lee obtained her Master’s Degree in Medical Statistics from the Catholic University of Korea, College of Medicine and has played significant roles at various pharmaceutical companies and Contract Research Organizations (CROs). She served as the Executive Director of Statistical Analysis at Dream CIS and as the Director of Data Management (DM) at Novotech, where she gained extensive experience in clinical trial data analysis and management across various therapeutic areas, including oncology, cardiology, and endocrinology.
Especially, after first encountering CDISC (Clinical Data Interchange Standards Consortium) at Korea Otsuka Pharmaceutical in 2008, she has successfully led CDISC-based projects as Data Management Manager at LSK Global PS, overseeing the provision of CDISC packages. Later at Novotech, she enhanced quality in accordance with global standards and effectively integrated data and statistical analysis tasks, building internationally recognized expertise in data management.”
Kwunho Jeong, CEO of JNPMEDI stated, “CDISC compliance is essential for global clinical trials. With Director Lee’s recruitement we aim to further enhance data management in terms of consistency and correctness, and this will boost the efficiency of developing new drugs and raise our competitiveness in the global market.”
| Expected to Further Enhance the Competitiveness in CDISC Based Global Clinical Trial Data Management & Analysis
JNPMEDI (CEO, Kwunho Jeong) introduced on the 20th, the Executive Director HyunSoo Lee, who has over 20 years of careers in clinical trial statistical analysis. Through this recruitment, it is expected to strenghthen JNPMEDI’s capabilities in global clinical trial data management and analysis.
Director HyunSoo Lee obtained her Master’s Degree in Medical Statistics from the Catholic University of Korea, College of Medicine and has played significant roles at various pharmaceutical companies and Contract Research Organizations (CROs). She served as the Executive Director of Statistical Analysis at Dream CIS and as the Director of Data Management (DM) at Novotech, where she gained extensive experience in clinical trial data analysis and management across various therapeutic areas, including oncology, cardiology, and endocrinology.
Especially, after first encountering CDISC (Clinical Data Interchange Standards Consortium) at Korea Otsuka Pharmaceutical in 2008, she has successfully led CDISC-based projects as Data Management Manager at LSK Global PS, overseeing the provision of CDISC packages. Later at Novotech, she enhanced quality in accordance with global standards and effectively integrated data and statistical analysis tasks, building internationally recognized expertise in data management.”
Kwunho Jeong, CEO of JNPMEDI stated, “CDISC compliance is essential for global clinical trials. With Director Lee’s recruitement we aim to further enhance data management in terms of consistency and correctness, and this will boost the efficiency of developing new drugs and raise our competitiveness in the global market.”